Brief: Jubilant Pharmova Says USFDA Determines Inspection Classification Of 'Voluntary Action Indicated' For Roorkee Facility
April 17 (Reuters) - Jubilant Pharmova Ltd JUBA.NS :
* USFDA DETERMINES INSPECTION CLASSIFICATION OF 'VOLUNTARY
ACTION
INDICATED' FOR SOLID DOSAGE MANUFACTURING FACILITY AT ROORKEE
* FACILITY IS CONSIDERED TO BE IN ACCEPTABLE STATE OF
COMPLIANCE
WITH REGARD TO CURRENT GOOD MANUFACTURING PRACTICES
Source text for Eikon: ID:nBSE4MK70w
Further company coverage: JUBA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jubilant Pharmova
See all newsBrief: Jubilant Pharmova Sept-Quarter Consol Net Profit 312 Million Rupees
Brief: Jubilant Pharmova Says Jubilant Therapeutics Announces Oral Presentation Of Preliminary Phase 1 Clinical Data For JBI-802
India New Issue-Jubilant Pharmova to issue 3-year bonds, bankers say
India's Jubilant Pharmova eyes $150 mln through rupee debt sale, bankers say
Brief: Jubilant Pharmova To Consider Raising Of Funds Through Issuance Of Non- Convertible Debentures